Will US FDA User Fee Reauthorization Bring More RATS?

Congress should broaden scope of the 21st Century Cures’ regenerative advanced therapies (RAT) program to include gene therapies and other innovative treatments for rare diseases, attorney Sasinowski says, suggesting such an expansion could be part of the PDUFA legislation.

Capitol House

More from Rare Diseases

More from Pink Sheet